Experimental and Clinical Gastroenterology
Cure8 research brief
Why This Matters
People with IBD who undergo liver transplantation — especially those with PSC — can have different UC course and treatment needs because transplant immunosuppression and the liver disease itself affect the bowel.
Understanding these differences helps patients and clinicians plan follow-up and choose therapies that balance IBD control with transplant safety.
Who Should Pay Attention
Adults with ulcerative colitis, especially those with PSC or who are undergoing or have had liver transplantation; transplant clinicians and gastroenterologists managing IBD in post-transplant patients.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a literature-review article examining how ulcerative colitis behaves and is treated in patients who have undergone liver transplantation.
It summarizes proposed pathogenic mechanisms linking liver disease (notably primary sclerosing cholangitis) and IBD, and reviews efficacy and safety of immunosuppressive drugs and IBD therapies used after transplant.
Keep In Mind
This article is a literature review (abstract-level content provided). It summarizes published studies rather than reporting new trial data. Treatment recommendations must be individualized with transplant and IBD specialists because immunosuppressive regimens and infection risks complicate therapy choices.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationExperimental and Clinical Gastroenterology
PublisherLLC Global Media Technology
AuthorsT. O. Smirnova, V. E. Syutkin, O. V. Parinov +1 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 18, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Application of thermo-responsive polymers as an enema formulation for the treatment of ulcerative colitis.
A rectal 5-ASA gel that forms in place and sticks to the mucosa could reduce leakage and improve drug retention, potentially increasing effectiveness and patient comfort for people using topical therapies for ulcerative...
Human factors validation study of a disposable autoinjector (Bmab 1200 autoinjector) for subcutaneous delivery of Ustekinumab.
Autoinjectors can make long-term biologic treatment easier, more convenient, and potentially improve adherence for people with Crohn’s disease or ulcerative colitis who use ustekinumab.
Rectal stump management in paediatric ulcerative colitis—An international survey for the ESPGHAN PORTO IBD group study
The survey highlights wide variation in how rectal stumps are assessed and managed after colectomy in children with UC, indicating uncertainty and a gap in standardised care that could affect outcomes and follow-up...